Dr. Rampurwala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-834-7374
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2012 - 2015
- University of ConnecticutResidency, Internal Medicine, 2009 - 2012
- Government Medical College GujuratClass of 2007
Certifications & Licensure
- IL State Medical License 2016 - 2026
- WI State Medical License 2012 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer.Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Kelly J Wilkinson, Emily M Whitman-Purves
Clinical Cancer Research. 2024-12-16 - 1 citationsFinal analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant.Benjamin A Derman, Jennifer Cooperrider, Jacalyn Rosenblatt, David E Avigan, Murtuza Rampurwala
Blood Cancer Journal. 2024-05-29 - Optimal breast cancer risk reduction policies tailored to personal risk level.Mehmet A Ergun, Ali Hajjar, Oguzhan Alagoz, Murtuza Rampurwala
Health Care Management Science. 2022-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: